@article{14741f9b57114237ba3c7edaec78e658,
title = "Risk Stratification and Prediction in Beta-Lactam Allergic Patients",
author = "Allison Ramsey and Caubet, {Jean Christoph} and Kimberly Blumenthal",
note = "Funding Information: No funding was received for this work. Conflicts of interest: A. Ramsey has received research funding from CSL-Behring, Takeda (formerly Shire), and Regeneron; and is on the speakers bureau for Regeneron, none of which is relevant to this Editorial. J.-C. Caubet declares no relevant conflicts of interest. K. Blumenthal has received research support from the National Institutes of Health (Grant No. NIH K01AI125631), American Academy of Allergy, Asthma, and Immunology (AAAAI) Foundation (2016 AAAAI Foundation & Phil and Barbara Lieberman Faculty Development Award), Massachusetts General Hospital (MGH Claflin Distinguished Scholar Award), and CRICO (Assessing Allergy Safety During Electronic Health Record Transitions); and reports a clinical decision support tool used institutionally for beta-lactam allergy at Partners HealthCare System that is licensed to Persistent Systems.",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.jaip.2019.05.045",
language = "English",
volume = "7",
pages = "2182--2184",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "American Academy of Allergy, Asthma and Immunology",
number = "7",
}